The genetic culprits responsible for the spread of multidrug resistance (MDR) in bacteria have been identified by new ...

Many applications—from drug discovery and diagnostics to cell engineering and gene modulation—require delivering biomolecules ...

This eBook will go beyond just talking about how to streamline manufacturing but also provide in-depth insights into topics that aren’t always covered to the same degree but are just as important to ...

Half-year Report. PR Newswire. LONDON, United Kingdom, September 29. Press Release. 4basebio PLC ("4basebio", the "Company" or the "Group") Half-year Report for the ...

Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept (GLOBE ...

IMNN-001 continues to show a favorable safety profile.

In this GEN webinar, our expert speakers will present a case study demonstrating the exceptional properties and high-fidelity performance of ENFINIA Linear DNA.

The webcast will be available for 90 days at the link above or under the News & Investors tab of the Imunon website at IMUNON is a clinical-stage biotechnology company focused on advancing a ...

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Airfloa Rail Technology IPO: The initial public offer (IPO) of Airfloa Rail Technology sailed through on the first day of the bidding process on Thursday, September 11, amid a strong grey market ...

Technology offers significant benefits across virtually all aspects of modern life, including improved communication, exponential growth in information access, increased productivity and automation, ...